Crescent Biopharma, Inc.
CBIO
$18.00
$0.724.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.27% | 59.98% | -12.70% | 580.57% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 17.15% | 320.88% | -17.95% | 286.80% | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | -17.36% | 75.87% | -12.75% | 575.31% | |
|
|
|||||
| Total Current Assets | -17.36% | 75.87% | -12.75% | 575.31% | |
| Net Property, Plant & Equipment | -0.60% | -1.32% | 30.33% | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -4.31% | -2.72% | -3.27% | -49.19% | |
| Total Assets | -17.13% | 73.79% | -12.17% | 514.85% | |
|
|
|||||
| Total Accounts Payable | -88.10% | 290.36% | 55.40% | 159.94% | |
| Total Accrued Expenses | -47.75% | -44.32% | 19.13% | 0.12% | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 4.14% | 4.32% | 97.63% | -- | |
| Total Finance Division Other Current Liabilities | -52.69% | 721.65% | -0.38% | 139.82% | |
| Total Other Current Liabilities | -52.69% | 721.65% | -0.38% | 139.82% | |
| Total Current Liabilities | -60.65% | 77.66% | 21.25% | 17.24% | |
|
|
|||||
| Total Current Liabilities | -60.65% | 77.66% | 21.25% | 17.24% | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -9.84% | -8.69% | -7.61% | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -59.01% | 72.37% | 18.97% | -64.88% | |
|
|
|||||
| Common Stock & APIC | 1.11% | 93.08% | 1.05% | 6,559.39% | |
| Retained Earnings | -13.55% | -116.35% | -44.90% | -66.00% | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -9.63% | 76.68% | -16.72% | 548.44% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | |
|
|
|||||
| Total Common Equity | -9.63% | 76.68% | -16.72% | 548.44% | |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -9.44% | 74.05% | -16.24% | 632.30% | |
|
|
|||||